题名 | Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes |
作者 | |
通讯作者 | Chen, Guo-Chong |
发表日期 | 2023-08-14
|
DOI | |
发表期刊 | |
ISSN | 1078-0998
|
EISSN | 1536-4844
|
摘要 | Background Inflammatory bowel disease (IBD) was associated with elevated risk of cardiometabolic diseases in observational studies. We aimed to evaluate the observational and genetic associations of Crohn's disease (CD) and ulcerative colitis (UC) with multiple cardiometabolic outcomes.Methods Our phenotypic and genetic association analyses included more than 400 000 participants who were free of major cardiovascular disease and diabetes at recruitment (2006-2010) and were followed up until December 2019 based on the UK Biobank. For the Mendelian randomization (MR) analyses, 415 and 273 single nucleotide polymorphisms associated with CD and UC, respectively, were selected as genetic instruments. Summary-level data on individual cardiometabolic outcomes were obtained from 4 different genome-wide association studies with a total of 2 248 842 participants.Results In the multivariable-adjusted observational analyses, CD was associated with higher risks of heart failure (hazard ratio [HR], 1.72; 95% confidence interval, 1.22-2.42) and type 2 diabetes (HR, 2.11; 95% confidence interval, 1.67-2.67) but not with myocardial infarction or ischemic stroke. UC was related to increased risks of all the assessed cardiometabolic diseases (HRs ranged from 1.29 for myocardial infarction to 1.76 for type 2 diabetes). Conversely, neither the genetic risk score for CD nor that for UC was associated with higher risk of developing cardiometabolic diseases. In 2-sample MR analyses, genetically determined CD and UC were not associated with any of the assessed cardiometabolic diseases (all P values >.05).Conclusions Despite confirming the observational associations, our study does not support a causal association between IBD and elevated risk of cardiometabolic diseases. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
资助项目 | null[60009]
|
WOS研究方向 | Gastroenterology & Hepatology
|
WOS类目 | Gastroenterology & Hepatology
|
WOS记录号 | WOS:001056797100001
|
出版者 | |
ESI学科分类 | CLINICAL MEDICINE
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:1
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/553568 |
专题 | 南方科技大学医学院_公共卫生及应急管理学院 |
作者单位 | 1.Soochow Univ, Suzhou Med Coll, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China 2.Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, Suzhou Med Coll, Suzhou, Peoples R China 3.Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA 4.Southern Univ Sci & Technol, Sch Publ Hlth & Emergency Management, Shenzhen, Peoples R China 5.Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA 6.Nantong Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Nantong, Peoples R China 7.Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China 8.Soochow Univ, Suzhou Med Coll, Sch Nursing, Suzhou, Peoples R China 9.Soochow Univ, Suzhou Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Suzhou, Peoples R China 10.Soochow Univ, Suzhou Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, 199 Renai Rd,Ind Pk Dist, Suzhou 215123, Jiangsu, Peoples R China 11.Soochow Univ, Suzhou Med Coll, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, 199 Renai Rd,Ind Pk Dist, Suzhou 215123, Jiangsu, Peoples R China |
推荐引用方式 GB/T 7714 |
Zhu, Zhengbao,Jia, Yiming,Li, Fu-Rong,et al. Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes[J]. INFLAMMATORY BOWEL DISEASES,2023.
|
APA |
Zhu, Zhengbao.,Jia, Yiming.,Li, Fu-Rong.,Li, Yang.,Chen, Li-Hua.,...&Chen, Guo-Chong.(2023).Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes.INFLAMMATORY BOWEL DISEASES.
|
MLA |
Zhu, Zhengbao,et al."Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes".INFLAMMATORY BOWEL DISEASES (2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论